Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Evofem Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 examiner and 1 art unit, indicating a single examination path.
BAZARGANI, ARYA AHMADI is the identified busiest examiner and handles 1 pending matter. Prosecution preparation should focus on the examiner’s biotechnology analysis and the claims supported by the application.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18407371 | COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES USING AN ALGINIC ACID-BASED ANTIMICROBIAL COMPOUND | HELM, CARALYNNE E | 40d |
| 18705917 | RAPIDLY DISSOLVING VAGINAL FILM WITH CONTRACEPTIVE ACTION AND SEXUALLY TRANSMITTED INFECTION PREVENTION | BAZARGANI, ARYA AHMADI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18407371 | COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES USING AN ALGINIC ACID-BASED ANTIMICROBIAL COMPOUND | HELM, CARALYNNE E | 40d |
| 18705917 | RAPIDLY DISSOLVING VAGINAL FILM WITH CONTRACEPTIVE ACTION AND SEXUALLY TRANSMITTED INFECTION PREVENTION | BAZARGANI, ARYA AHMADI | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18705917 | RAPIDLY DISSOLVING VAGINAL FILM WITH CONTRACEPTIVE ACTION AND SEXUALLY TRANSMITTED INFECTION PREVENTION | BAZARGANI, ARYA AHMADI | 1613 | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18407371 | COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES USING AN ALGINIC ACID-BASED ANTIMICROBIAL COMPOUND | HELM, CARALYNNE E | 1615 | §103§112Other | Final Rejection | 40d | Pending | Jan 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEvofem Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Arya Ahmadi Bazargani has the most, with 1 of Evofem Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.